Evidence map›Paper›PMID 40640798›Full record

ArticleRespiratory research2025

Transcriptome reveals the landscape of alveolar macrophages exposed to combined hypoxia with cigarette smoke extract.

Qing Liu, Yushi Zhang, Ruirui Duan, Wanheng Li, Xuan Hou, Yiling Chen, Baicun Li, Ting Yang

Abstract read
In one paragraph

Article in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. International journal of chronic obstructive pulmonary disease · 2026
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qing Liu *Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.
Yushi Zhang *National Clinical Research Center for Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Ruirui Duan *National Clinical Research Center for Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Wanheng LiNational Clinical Research Center for Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Xuan HouNational Clinical Research Center for Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Yiling Chen *National Clinical Research Center for Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China. 2504182399@qq.com.
Baicun Li *National Clinical Research Center for Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China. lbc19890303@126.com.
Ting Yang *Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China. zryyyangting@163.com.

Funding

Fundamental Research Funds for the Central Universities 3332023095Fundamental Research Funds for the Central Universities 3332024099National Key Research and Development Program of China 2022YFF0710803National Natural Science Foundation of China 82300051National Natural Science Foundation of China 82400053National Natural Science Foundation of China U24A20644Noncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0528403
6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) is a complex and heterogeneous chronic inflammatory disease that is one of the leading causes of age-standardised deaths globally. While studies have investigated altitude's effects on COPD, none have explored alveolar macrophage homeostatic alterations during its pathogenesis at high altitudes.

methodsWe constructed a high-altitude COPD model through exposure of mouse alveolar macrophages (MH-S) to hypoxia and cigarette smoke extract (CSE). Hypoxia-inducible factor (HIF) expression was quantified in MH-S cells exposed to hypoxia combined with CSE and in the control group. HIF-1α short hairpin RNA (shRNA) was added to the MH-S cells. Transcriptome was used to characterise downstream signalling pathways of HIF-1α in MH-S cells treated with hypoxia and CSE exposure. Standard molecular techniques were used to validate the RNA sequencing results.

resultsHIF-1α but not HIF-2α was significantly up-regulated in MH-S cells after exposure to hypoxia and CSE. RNA-sequencing analysis of MH-S cells showed the relevant pathways downstream of HIF-1α are mainly inflammation, glycolysis, M1 polarization, extracellular matrix remodelling and angiogenesis. Validation of RNA-sequencing analysis confirmed that the above signalling pathways were abnormally up-regulated after CSE exposure, and that combined hypoxic exposure further exacerbated the induced aberrant up-regulation, which was inhibited after treatment with HIF-1α shRNA.

conclusionDownstream HIF-1α signalling pathways drive inflammation, M1 macrophage polarization, glycolysis, extracellular matrix remodelling, and angiogenesis, potentially disrupting alveolar macrophages homeostasis during high-altitude COPD pathogenesis. This disruption may be one reason underlying the high prevalence of COPD in high-altitude regions.

Indexed as

Cigarette SmokingHypoxiaMacrophages, AlveolarPulmonary Disease, Chronic ObstructiveSmokeTranscriptomeAnimalsCell HypoxiaCells, CulturedHypoxia-Inducible Factor 1, alpha SubunitMiceMice, Inbred C57BLHypoxia-Inducible Factor 1, alpha SubunitSmokeAlveolar macrophage homeostasisChronic obstructive pulmonary diseaseCigarette smoke extractHIF-1αHypoxia

Identifiers

PMID40640798
PMCPMC12243345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.